A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition

The epithelial-mesenchymal transition (EMT) is an important process during metastasis in various tumors, including colorectal cancer (CRC). Thus, the study of its characteristics and related genes is of great significance for CRC treatment. In this study, 26 EMT-related gene sets were used to score...

Full description

Bibliographic Details
Main Authors: Hongyu Huang, Tianyou Li, Ziqi Meng, Xueqian Zhang, Shanshan Jiang, Mengying Suo, Na Li
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/17/13206
_version_ 1797582459838136320
author Hongyu Huang
Tianyou Li
Ziqi Meng
Xueqian Zhang
Shanshan Jiang
Mengying Suo
Na Li
author_facet Hongyu Huang
Tianyou Li
Ziqi Meng
Xueqian Zhang
Shanshan Jiang
Mengying Suo
Na Li
author_sort Hongyu Huang
collection DOAJ
description The epithelial-mesenchymal transition (EMT) is an important process during metastasis in various tumors, including colorectal cancer (CRC). Thus, the study of its characteristics and related genes is of great significance for CRC treatment. In this study, 26 EMT-related gene sets were used to score each sample from The Cancer Genome Atlas program (TCGA) colon adenocarcinoma (COAD) database. Based on the 26 EMT enrichment scores for each sample, we performed unsupervised cluster analysis and classified the TCGA-COAD samples into three EMT clusters. Then, weighted gene co-expression network analysis (WGCNA) was used to investigate the gene modules that were significantly associated with these three EMT clusters. Two gene modules that were strongly positively correlated with the EMT cluster 2 (worst prognosis) were subjected to Cox regression and least absolute shrinkage and selection operator (LASSO) regression analysis. Then, a prognosis-related risk model composed of three hub genes <i>GPRC5B</i>, <i>LSAMP</i>, and <i>PDGFRA</i> was established. The TCGA rectal adenocarcinoma (READ) dataset and a CRC dataset from the Gene Expression Omnibus (GEO) were used as the validation sets. A novel nomogram that incorporated the risk model and clinicopathological features was developed to predict the clinical outcomes of the COAD patients. The risk model served as an independent prognostic factor. It showed good predictive power for overall survival (OS), immunotherapy efficacy, and drug sensitivity in the COAD patients. Our study provides a comprehensive evaluation of the clinical relevance of this three-gene risk model for COAD patients and a deeper understanding of the role of EMT-related genes in COAD.
first_indexed 2024-03-10T23:21:31Z
format Article
id doaj.art-7ebc4ea2fe584a21bab9c78941e8141f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T23:21:31Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-7ebc4ea2fe584a21bab9c78941e8141f2023-11-19T08:13:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-08-0124171320610.3390/ijms241713206A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal TransitionHongyu Huang0Tianyou Li1Ziqi Meng2Xueqian Zhang3Shanshan Jiang4Mengying Suo5Na Li6School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, ChinaThe epithelial-mesenchymal transition (EMT) is an important process during metastasis in various tumors, including colorectal cancer (CRC). Thus, the study of its characteristics and related genes is of great significance for CRC treatment. In this study, 26 EMT-related gene sets were used to score each sample from The Cancer Genome Atlas program (TCGA) colon adenocarcinoma (COAD) database. Based on the 26 EMT enrichment scores for each sample, we performed unsupervised cluster analysis and classified the TCGA-COAD samples into three EMT clusters. Then, weighted gene co-expression network analysis (WGCNA) was used to investigate the gene modules that were significantly associated with these three EMT clusters. Two gene modules that were strongly positively correlated with the EMT cluster 2 (worst prognosis) were subjected to Cox regression and least absolute shrinkage and selection operator (LASSO) regression analysis. Then, a prognosis-related risk model composed of three hub genes <i>GPRC5B</i>, <i>LSAMP</i>, and <i>PDGFRA</i> was established. The TCGA rectal adenocarcinoma (READ) dataset and a CRC dataset from the Gene Expression Omnibus (GEO) were used as the validation sets. A novel nomogram that incorporated the risk model and clinicopathological features was developed to predict the clinical outcomes of the COAD patients. The risk model served as an independent prognostic factor. It showed good predictive power for overall survival (OS), immunotherapy efficacy, and drug sensitivity in the COAD patients. Our study provides a comprehensive evaluation of the clinical relevance of this three-gene risk model for COAD patients and a deeper understanding of the role of EMT-related genes in COAD.https://www.mdpi.com/1422-0067/24/17/13206CRCEMTmultigene prognosis-related risk modelclinical significancetherapeutic response
spellingShingle Hongyu Huang
Tianyou Li
Ziqi Meng
Xueqian Zhang
Shanshan Jiang
Mengying Suo
Na Li
A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition
International Journal of Molecular Sciences
CRC
EMT
multigene prognosis-related risk model
clinical significance
therapeutic response
title A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition
title_full A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition
title_fullStr A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition
title_full_unstemmed A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition
title_short A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition
title_sort risk model for prognosis and treatment response prediction in colon adenocarcinoma based on genes associated with the characteristics of the epithelial mesenchymal transition
topic CRC
EMT
multigene prognosis-related risk model
clinical significance
therapeutic response
url https://www.mdpi.com/1422-0067/24/17/13206
work_keys_str_mv AT hongyuhuang ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT tianyouli ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT ziqimeng ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT xueqianzhang ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT shanshanjiang ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT mengyingsuo ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT nali ariskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT hongyuhuang riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT tianyouli riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT ziqimeng riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT xueqianzhang riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT shanshanjiang riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT mengyingsuo riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition
AT nali riskmodelforprognosisandtreatmentresponsepredictionincolonadenocarcinomabasedongenesassociatedwiththecharacteristicsoftheepithelialmesenchymaltransition